InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-18 · accession 0001649094-24-000018 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-06-20 2024-06-18 PCVX GUGGENHIME ANDREW Pres AND CFO S - Sale+OE $71.92 -8,000 96.7K -8% -$575.4K
D 2024-06-20 2024-06-18 PCVX GUGGENHIME ANDREW Pres AND CFO M - OptEx $5.35 +8,000 104.7K +8% +$42.8K
D 2024-06-20 2024-06-18 PCVX GUGGENHIME ANDREW Pres AND CFO M - OptEx $0.00 -8,000 344.8K -2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-18 S D 7,652 $71.89 97,068 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $71.415 to $72.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2024-06-18 S D 348 $72.56 96,720 D — — (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $72.48 to $72.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2024-06-18 M A 8,000 $5.35 104,720 D — — (F1) Includes 1,041 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024.
4 Derivative Stock Option (right to buy) 2024-06-18 M D 8,000 $0.00 344,827 D $5.35 · — to 2030-05-11 8,000 Common Stock (F5) 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter.